Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease

被引:8
|
作者
Fao, Ligia [1 ,2 ]
Coelho, Patricia [1 ]
Duarte, Luis [1 ]
Vilaca, Rita [1 ,3 ]
Hayden, Michael R. [4 ]
Mota, Sandra I. [1 ,3 ]
Rego, Ana Cristina [1 ,2 ,5 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Coimbra, Portugal
[3] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal
[4] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[5] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Polo 1 Rua Larga, P-3004504 Coimbra, Portugal
关键词
Src kinase; Fyn kinase; mutant huntingtin; mitochondria; Huntington disease; autophagy; MUTANT HUNTINGTIN; TYROSINE PHOSPHORYLATION; IN-VITRO; KINASE; AUTOPHAGY; NEURODEGENERATION; ACTIVATION; MECHANISM; MUTATION; SYSTEM;
D O I
10.1089/ars.2022.0001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder with no effective therapies. Mutant huntingtin protein (mHTT), the main HD proteinaceous hallmark, has been linked to reactive oxygen species (ROS) formation and mitochondrial dysfunction, among other pathological mechanisms. Importantly, Src-related kinases, c-Src and Fyn, are activated by ROS and regulate mitochondrial activity. However, c-Src/Fyn involvement in HD is largely unexplored. Thus, in this study, we aimed at exploring changes in Src/Fyn proteins in HD models and their role in defining altered mitochondrial function and dynamics and redox regulation.Results: We show, for the first time, that c-Src/Fyn phosphorylation/activation and proteins levels are decreased in several human and mouse HD models mainly due to autophagy degradation, concomitantly with mHtt-expressing cells showing enhanced TFEB-mediated autophagy induction and autophagy flux. c-Src/Fyn co-localization with mitochondria is also reduced. Importantly, the expression of constitutive active c-Src/Fyn to restore active Src kinase family (SKF) levels improves mitochondrial morphology and function, namely through improved mitochondrial transmembrane potential, mitochondrial basal respiration, and ATP production, but it did not affect mitophagy. In addition, constitutive active c-Src/Fyn expression diminishes the levels of reactive species in cells expressing mHTT.Innovation: This work supports a relevant role for c-Src/Fyn proteins in controlling mitochondrial function and redox regulation in HD, revealing a potential HD therapeutic target.Conclusion: c-Src/Fyn restoration in HD improves mitochondrial morphology and function, precluding the rise in oxidant species and cell death.
引用
收藏
页码:95 / 114
页数:20
相关论文
共 50 条
  • [31] Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum
    Oliveira, Jorge M. A.
    JOURNAL OF NEUROCHEMISTRY, 2010, 114 (01) : 1 - 12
  • [32] Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease
    Stuewe, Sven H.
    Goetze, Oliver
    Lukas, Carsten
    Klotz, Peter
    Hoffmann, Rainer
    Banasch, Matthias
    Orth, Michael
    Schmidt, Wolfgang E.
    Gold, Ralf
    Saft, Carsten
    NEUROLOGY, 2013, 80 (08) : 743 - 746
  • [33] c-Src kinase impairs the expression of mitochondrial OXPHOS complexes in liver cancer
    Hunter, Caroline A.
    Koc, Hasan
    Koc, Emine C.
    CELLULAR SIGNALLING, 2020, 72
  • [34] C-src Phosphorylates the Mitochondrial Ca2+ Uniporter in Nonischemic Cardiomyopathy
    Xie, An
    Kang, Gyeoung-Jin
    Kim, Eun Ji
    Polina, Iuliia
    Feng, Feng
    Jhun, Bong Sook
    O-uchi, Jin
    Dudley, Samuel C.
    CIRCULATION, 2020, 142
  • [35] Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction
    Shi, S
    Garcia, JGN
    Roy, S
    Parinandi, NL
    Natarajan, V
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (03) : L441 - L451
  • [36] Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically
    Agrawal, Sonal
    Fox, Julia
    Thyagarajan, Baskaran
    Fox, Jonathan H.
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 120 : 317 - 329
  • [37] Olfactory Dysfunction in Huntington's Disease
    Patino, Jorge
    Karagas, Nicholas E.
    Chandra, Shivika
    Thakur, Nivedita
    Stimming, Erin Furr
    JOURNAL OF HUNTINGTONS DISEASE, 2021, 10 (04) : 413 - 422
  • [38] Nucleolar dysfunction in Huntington's disease
    Lee, Junghee
    Hwang, Yu Jin
    Ryu, Hyun
    Kowall, Neil W.
    Ryu, Hoon
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (06): : 785 - 790
  • [39] Critical role of c-Src Tyrosine Kinase, but not Fyn Tyrosine Kinase, in Ang II-induced hypertension
    Touyz, RM
    Endemann, D
    Ying, H
    Yao, GY
    Savoia, C
    Virdis, A
    Schiffrin, EL
    CIRCULATION, 2003, 108 (17) : 77 - 77
  • [40] Presynaptic dysfunction in Huntington's disease
    Rozas, Jose L.
    Gomez-Sanchez, Leonardo
    Tomas-Zapico, Cristina
    Lucas, Jose J.
    Fernandez-Chacon, Rafael
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 488 - 492